Search

Author/Creator McMillan, Hugh

1. 014 AVXS-101 gene-replacement therapy (GRT) in presymptomatic spinal muscular atrophy (SMA): study update. (29th July 2019)

Authors:
Farrar, Michelle; Swoboda, Kathryn J; Schultz, Meredith; McMillan, Hugh; Parsons, Julie; Alexander, Ian E; Kernbauer, Elaine; Farrow, Marcia; Ogrinc, Francis G; Feltner, Douglas E; McGill, Bryan E; Spector, Sidney A; L'Italien, James; Sproule, Douglas M; Strauss, Kevin A
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 90(2019)e7
Page Start:
A5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d'excellence en santé et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy. (24th July 2018)

Authors:
Campbell, Craig; Selby, Kathy; McMillan, Hugh; Vajsar, Jiri; Korngut, Lawrence; Brais, Bernard; MacKenzie, Alex; Oskoui, Maryam
Journal:
Canadian journal of neurological sciences
Issue:
Volume 45:Number 5(2018)
Page Start:
516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Survival Motor Neuron Protein is Released from Cells in Exosomes: A Potential Biomarker for Spinal Muscular Atrophy. Issue 1 (December 2017)

Authors:
Nash, Leslie; McFall, Emily; Perozzo, Amanda; Turner, Maddison; Poulin, Kathy; De Repentigny, Yves; Burns, Joseph; McMillan, Hugh; Warman Chardon, Jodi; Burger, Dylan; Kothary, Rashmi; Parks, Robin
Journal:
Scientific reports
Issue:
Volume 7:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗